News around you

AstraZeneca admits its Covishield vaccine may lead to rare side effect

Covishield, in rare instances, can induce a condition resulting in blood clots and decreased platelet count -the symptoms point to TTS- Thrombosis with Thrombocytopenia Syndrome.

AstraZenecaNew Delhi: In a significant development, AstraZeneca has admitted for the first time in court documents that its Covid-19 vaccine, sold globally under the brand names Covishield and Vaxzevria among others, may lead to a rare side-effect.

As stated by the manufacturer, Covishield, in rare instances, can induce a condition resulting in blood clots and decreased platelet count -the symptoms point to TTS — Thrombosis with Thrombocytopenia Syndrome — which also causes people to have blood clots and a low blood platelet count.

The vaccine which was developed by AstraZeneca and Oxford University, was manufactured by the Serum Institute of India and was widely administered across India and other low-and-middle-income countries.

AstraZeneca is facing a class action lawsuit in the UK, alleging its vaccine led to fatalities and severe brain injuries in numerous instances. Victims in 51 cases filed in the UK High Court are pursuing damages totaling up to 100 million pounds.

As reported, although AstraZeneca is disputing the allegations, it acknowledged in a legal filing submitted to the High Court in February that the vaccine “can, in very rare instances.”

In 2023, the first case was initiated by Jamie Scott, alleging a permanent brain injury post-vaccination in April 2021. AstraZeneca, in a May 2023 response to Scott’s lawyers, contested any direct link between the vaccine and TTS, stating they do not accept such a connection.

Kate Scott, Jamie Scott’s wife, told, “The medical world has acknowledged for a long time that VITT (vaccine induced immune thrombosis with thrombocytopenia) was caused by the vaccine. It’s only AstraZeneca who have questioned whether Jamie’s condition was caused by the jab… It’s taken three years for this admission to come. It’s progress, but we would like to see more from them and the Government. It’s time for things to move more quickly.”

In its statement, AstraZeneca expressed sympathy for individuals who have lost loved ones or reported health problems. The company emphasized that patient safety is its highest priority, with regulatory authorities maintaining clear and stringent standards for the safe use of all medicines, including vaccines.

You might also like

Comments are closed.